Sanofi ensures that France is at the centre of its strategy

The pharmaceutical company refuses to qualify as a "plan social" its intention to eliminate up to 1,000 jobs in France.

France is in the "centre" of the strategy of Sanofi, has assured on Saturday Paul Hudson, the director-general of the pharmaceutical group, refusing to be called "social plan" of its intention to remove approximately 1000 jobs.

"I confirm the willingness of the company to give more than ever to France a central place in its strategy. We are going to make massive investments in particular, to construct a plant new generation of vaccine manufacturing center in Neuville-sur-Saône, which will create several hundred new jobs," he said in a press release. "We need to help build sovereignty health of Europe and France," he adds.

READ ALSO >> Vaccine against the Covid-19 : Sanofi is not part of the 5 candidates selected by Trump

Your support is essential. Subscribe for $ 1 support Us

According to him, "the measures that we present in France today are not a new social plan, they are the result of strategic choices clear to the scale of the group that are putting France at the centre. This will see in the coming months and coming years".

1700 job cuts in Europe

Sanofi announced Friday want to remove up to 1700 jobs in Europe, including one thousand in France, on a background of a growing turnover, causing the anger of unions while just a year after the announcement of a previous plan of headcount reduction.

READ ALSO >> André Loesekrug-Pietri : "The CEO of Sanofi is right on the lack of european response"

The officer explains to want to recruit "new skills" (artificial intelligence, gene therapy) and make "adjustments to staffing in certain areas". "In France, about a thousand posts about the 25 000 that the group will be deleted in the three years that come in the form of volunteering, so an average of 350 per year," says Paul Hudson.

According to the Newspaper Sunday, two planes of rupture conventionnelle collective (RCC) will be offered Monday to the committee on business France, for Sanofi-Aventis and the other for Sanofi Winthrop, aimed at total 523 voluntary departures of employees with at least 10 years of service and a professional project. The group has not confirmed these elements.

Read our complete file

Sanofi

Sanofi wants to remove a thousand jobs in France, a plan "shameful" for the unions Vaccine against the Covid-19 : Sanofi would not be part of the 5 candidates selected by Trump Pharmacy: Sanofi announces the sale of its share in Regeneron

Jean-Marc Burlet, of the CFE-CGC, confirmed to have knowledge of a proposition a priori of the CBI, so departures on a voluntary basis", without, however, details are encrypted.